Role of diagnostic imaging in psoriatic arthritis: how, when, and why

• Published in: Insights into imaging 2021-08, Vol.12 (1), p.121-121, Article 121
• Main Authors: Crespo-Rodríguez, Ana María, Sanz Sanz, Jesús, Freites, Dalifer, Rosales, Zulema, Abasolo, Lydia, Arrazola, Juan
• Format: Article
• Language: English
• Subjects: Arthritis; Diagnosis; Diagnostic Radiology; Educational Review; Health services; Heterogeneity; Imaging; Imaging techniques; Internal Medicine; Interventional Radiology; Magnetic resonance imaging; Medical diagnosis; Medical imaging; Medicine; Medicine & Public Health; Neuroradiology; Psoriasis; Psoriatic arthritis; Radiography; Radiology; Structural damage; Ultrasound
• ISSN: 1869-4101; 1869-4101
• DOI: 10.1186/s13244-021-01035-0

Psoriasis is a common skin disease. Up to 30% of patients with psoriasis develop psoriatic arthritis (PsA) resulting, by far, the most prevalent coexisting condition. Heterogeneity of clinical and radiological presentation is a major challenge to diagnosis of PsA. Initial reports about PsA emphasized a benign course in most patients, but it is now recognized that psoriatic arthritis often leads to impaired function and a reduced quality of life. PsA is a progressive disease characterized by diverse clinical features, often resulting in diagnostic delay and treatment that are associated with poor clinical and structural outcomes. New effective treatments may halt PsA progression, and consequently, treatment goals have evolved from simple reduction of pain to achieving full remission or minimal disease activity. This emerging treat-to-target strategy paradigm emphasize a need for early diagnosis; sensitive imaging techniques may be of value in this process. While radiography and CT depict structural damage, US and MRI have emerged as helpful tools to evaluate magnitude and severity of active inflammatory lesions. This review aims to describe the role of imaging modalities in diagnosis, follow-up and prognosis of PsA.